Hasanova Sevinc

Department of Surgery, Medical University, Azerbaijan

*Corresponding Author: Hasanova Sevinc, Department of Surgery, Medical University, Azerbaijan.

Received: August 16, 2022; Published: September 23, 2022

Abstract

Acute pancreatitis (AP) is one of the most common gastrointestinal causes for hospitalization. In 2015, AP accounted for 390940 hospitalizations making it one of the most frequent causes of gastrointestinal hospitalizations in the nation with the annual incidence only expected to increase over time [1-3]. Despite recent advances in gastroenterology, AP continues to be associated with substantial mortality, morbidity and healthcare resource utilization [7,14,20].

Keywords: Acute Pancreatitis (AP); Stem Cell; American Gastroenterological Association (AGA)

References

1. Eşrefoğlu M., et al. “Antioxi-NICE. Pancreatitis: Diagnosis and Management Draft Scope for Consultation”. National Institute for Clinical Excellence; London, UK: (2016).
2. Whitcomb DC. “Acute pancreatitis”. The New England Journal of Medicine 20 (2006): 2142-2150.
3. Yadav D and Lowenfels AB. “Trends in the epidemiology of the first attack of acute pancreatitis”. Pancreas 4 (2006): 323-330.
4. Toouli J., et al. “Guidelines for the management of acute pancreatitis”. Journal of Gastroenterology and Hepatology 17 (2002): 515-539.
5. Venneman NG., et al. “Microlithiasis: an important cause of “idiopathic” acute pancreatitis?” Annals of Hepatology1 (2003): 30-35.
6. Wang GJ., et al. “Acute pancreatitis: etiology and common pathogenesis”. World Journal of Gastroenterology12 (2009): 1427-1430.
7. Sakorafas GH and Tsiotou AG. “Etiology and pathogenesis of acute pancreatitis: current concepts”. Journal of Clinical Gastroenterology4 (2000): 343-356.
8. “UK Working Party on Acute Pancreatitis UK guidelines for the management of acute pancreatitis”. Gut 54 (2005): 1-9.
9. Matull WR., et al. “Biochemical markers of acute pancreatitis”. Journal of Clinical Pathology 4 (2006): 340-344.
10. Ammori B., et al. “The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging”. Pancreas2 (2003): e32-e35.
11. Tenner S., et al. “Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis”. American Journal of Gastroenterology10 (1994): 1863-1866.
12. Carroll J., et al. “Acute pancreatitis: diagnosis, prognosis and treatment”. American Family Physician10 (2007): 1513-1520.
13. Banks PA., et al. “Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus”. Pancreas1 (2013): 102-111.
14. “BMJ Acute pancreatitis”. BMJ Best Practice (2017).
15. Cho JH., et al. “Comparison of scoring systems in predicting the severity of acute pancreatitis”. World Journal of Gastroenterology8 (2015): 2387-2394.
16. Wilson C., et al. “Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems”. British Journal of Surgery11 (1990): 1260-1264.
17. Papachristou GI., et al. “Comparison of BISAP, Ranson’s, APACHE II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis”. American Journal of Gastroenterology2 (2010): 435-441.
18. “18.dative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats”. World Journal of Gastroenterology 12 (2006): 259-264.
19. Eşrefoğlu M., et al. “Ultrastructural clues for the protective effect of melatonin against oxidative damage in cerulein-induced pancreatitis”. Journal of Pineal Research 40 (2006): 92-97.
20. Esrefoglu M. “Stem Cell Therapies on Pancreatitis”. In: Rodrigo L, editor. Acute and Chronic Pancreatitis. Rijeka: InTech; (2015): 08.
21. Ben Nasr M., et al. “Adipose Stem Cell Therapy for Chronic Pancreatitis”. Molecular Therapy 25 (2017): 2438-2439.
22. Karaoz E., et al. “Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulinproducing cells in pancreatic islet microenvironment both in vitro and in vivo”. Cytotherapy 15 (2013): 557-570.
23. Jung KH., et al. “Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats”. Gastroenterology 140 (2011): 998-1008.
24. Schneider G and Saur D. “Mesenchymal Stem Cells: Therapeutic Potential for Acute Pancreatitis”. Gastroenterology 140 (2011): 779-782.
25. Pittenger MF., et al. “Multiline age potential of adult human mesenchymal stem cells”. Science 284 (1999): 143-147.
26. Smukler SR., et al. “The adult mouse and human pancreas contain rare multipotent stem cells that express insulin”. Cell Stem Cell 8 (2010): 281-293.
27. Xu X., et al. “Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas”. Cell 132 (2008): 197-207.
28. Zhou Q., et al. “A multipotent progenitor domain guides pancreatic organogenesis”. Developmental Cell 13 (2007): 103-114.
29. Gong J., et al. “Experimental evidence supporting the lack of primary stem cells in adult pancreatic tissue”. Pancreatology 10 (2010): 620-630.

Citation

Citation: Hasanova Sevinc. “Stem Cell Therapies on Acute Pancreatitis". Acta Scientific Gastrointestinal Disorders 5.10 (2022): 12-16.

Copyright

Copyright: © 2022 Hasanova Sevinc. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.